Surface Oncology Inc SURF:NASDAQ

Last Price$1.76NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$1.67 (2)
Ask (Size)$1.86 (2)
Day Low / HighN/A - N/A

Top Premarket Gainers

8:11AM ET 9/17/2021 MT Newswires
Corvus Pharmaceuticals (CRVS) shares soared 52% following a small loss on Thursday.

Innate Pharma (IPHA) shares rallied 29% on positive phase 2 trial data for monalizumab plus durvalumab in non-small cell lung cancer patients.

Surface Oncology (SURF) shares rose 14% following an uptick in the previous session.

Beigene (BGNE) shares surged 14% after the company received a positive opinion from a key European Medicines Agency committee recommending approval of brukinsa to treat Waldenstrom's macroglobulinemia.